2793276|t|Tetrahydroaminoacridine in HIV infections. The THA Study Group.
2793276|a|On the basis of a similarity between certain neurological symptoms of AIDS and Alzheimer's disease, the authors studied the effects of tetrahydroaminoacridine (THA) in 9 patients with HIV infection. After 2 months of treatment, the preliminary results showed a significant increase in CD4 lymphocyte count as well as a decrease in p24 antigen level in 8 patients, of whom 4 became negative for the p24 antigen.
2793276	0	23	Tetrahydroaminoacridine	Chemical	MESH:D013619
2793276	27	41	HIV infections	Disease	MESH:D015658
2793276	47	50	THA	Chemical	MESH:D013619
2793276	109	121	neurological	Disease	MESH:D009461
2793276	134	138	AIDS	Disease	MESH:D000163
2793276	143	162	Alzheimer's disease	Disease	MESH:D000544
2793276	199	222	tetrahydroaminoacridine	Chemical	MESH:D013619
2793276	224	227	THA	Chemical	MESH:D013619
2793276	234	242	patients	Species	9606
2793276	248	261	HIV infection	Disease	MESH:D015658
2793276	349	352	CD4	Gene	920
2793276	395	398	p24	Gene	10959
2793276	418	426	patients	Species	9606
2793276	462	465	p24	Gene	10959
2793276	Negative_Correlation	MESH:D013619	MESH:D015658
2793276	Negative_Correlation	MESH:D013619	10959

